Coloritinib

Related products

• 

  Non-small cell lung cancer (NSCLC) , Melanoma

  nivolumab

  【Product name】Opdivo, pdivo

  [English common name]Nivolumab

  [Chinese common name]nivolumab

  [English name]Nye VOL ue mab

  [Chinese other name]Niluzumab

  [indications] can not be removed or transferredMelanoma
  OPDIVO (nivolumab) Navuzumab is indicated for the treatment of disease progression in patients with unremovable or metastatic melanoma and Iplimum and, such as BRAF V600 mutation-positive, a BRAF inhibitor.
  This indication is approved under accelerated approval based on the tumor response rate and the persistence of the response. The continuation of this indication may depend on the validation and description of the clinical benefit in the validation trial.
  Metastatic squamous non-small cell lung cancer
  OPDIVO (nivolumab) Nawu monoclonal antibody is suitable for metastasisNon-small cell lung cancer (NSCLC)Treatment with platinum-based chemotherapy or post-transfer patients.

  【Dosage】The recommended dose of OPDIVO is 3 mg/kg administered intravenously for 60 minutes every 2 weeks until disease progression or unacceptable toxicity.

  [Storage]Store OPDIVO in a refrigerator at 2 ° C to 8 ° C (36 ° F - 46 ° F). Protect OPDIVO Nawu mAb in the original package before use. Do not freeze or shake.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Non-small cell lung cancer (NSCLC)

  Gefitinib

  【Product name】Iressa

  [English common name]Gefitinib

  [Chinese common name]Gefitinib

  [English name]AKOS 91371, Gefitinib Base

  [Chinese other name]Ireco, Iressa

  [Indications] This product is suitable for the treatment of local advanced or metastatic treatment of previous chemotherapy.Non-small cell lung cancer (NSCLC) . Previous chemotherapy mainly refers to the treatment of platinum and docetaxel.

  【Dosage】
  The recommended dose of this product is 250mg (1 tablet), once a day, orally, on an empty stomach or with food.
  If you have difficulty swallowing, disperse the tablets in half a cup of drinking water (non-carbonated drinks). Do not use other liquids. The tablets were dropped into water without crushing, stirred until completely dispersed (about 10 minutes), and the liquid was immediately taken. Rinse the cup with half a cup of water and drink. The drug solution can also be administered through a nasal-stomach tube.
  There is no need to adjust the dose to be administered depending on the age, weight, sex, ethnicity, renal function, and moderate to severe liver damage caused by liver metastasis.
  Dose adjustment: When patients have intolerable diarrhea or skin reactions, they can be resolved by short-term suspension of treatment (up to 14 days), followed by a daily dose of 250 mg (see Adverse Reactions).
  Used in children
  There is currently no data on the safety and efficacy of this product for children or adolescents, so it is not recommended.

  [Storage] Store in original packaging to protect it from moisture.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Non-small cell lung cancer (NSCLC)

  Crizotiny

  【Product name】XALKORI

  [English common name]Crizotinib

  [Chinese common name]Crizotiny

  [English name]Crizotinib

  [Chinese other name]Crizotinib

  [Indications] XALKORI is a kinase inhibitor suitable for the treatment of the following patients:
  (1) TransferNon-small cell lung cancer (NSCLC)Tumors were tested for anaplastic lymphoma kinase (ALK)-positive using an FDA-approved test.
  (2) Metastatic NSCLC whose tumor is ROS1-positive.

  【Dosage】
  (1) Recommended dose: 250 mg orally, 2 times a day.
  (2) Kidney damage: 250 mg orally, once a day in patients with severe renal impairment (creatinine clearance <30 mL / min) without dialysis.

  [Storage]Pfizer Lab:20-25 ° C (may vary by 15-30 ° C).

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.
• 

  Non-small cell lung cancer (NSCLC)

  Erlotinib

  【Product name】Tarceva

  [English common name]Erlotinib

  [Chinese common name]Erlotinib

  [English name]Natco Pharma Ltd

  [Chinese other name]It

  [Indications] Tarceva is used for local advanced or metastatic failure of two or more chemotherapy regimensNon-small cell lung cancerThree-line treatment.

  [Usage and Dosage] This product must be used under the guidance of a doctor who has experience in the use of such drugs, and is only used in the National Cancer Drug Clinical Trial Base or the tertiary hospital. The recommended dose of erlotinib for single-cell lung cancer is 150 mg/day, at least 1 hour before eating or 2 hours after eating. Continue medication until the disease progresses or an intolerable toxic reaction occurs. There is no evidence that continued treatment after progression can benefit patients.

  [Storage] The drug does not require any special storage conditions.

  [Tips] Some of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctors to diagnose face to face. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.